R Montero Vallejo-rekin lankidetzan egindako argitalpenak (3)

2024

  1. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression

    United European Gastroenterology Journal, Vol. 12, Núm. 8, pp. 1056-1068

2022

  1. Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation

    Scientific Reports, Vol. 12, Núm. 1

2019

  1. Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models

    Revista Espanola de Enfermedades Digestivas, Vol. 111, Núm. 4, pp. 301-307